Q07E42 AF NFT

Cystic fibrosis transmembrane conductance regulator

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifo2muepcot6qxt7rtxoy2hkapr4jenzrdtryk7j5wz5lsr56bnti/metadata.json
IPFS of structure file: 
bafybeihsoeaf5uthzrdkuqzza3mlwj6dsy2c4wudanwoends5dhtjvhn6a/AF-Q07E42-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xF8cD1d8d93E9783063700De244A6e3cf6A195579
First NFT owner address (bech32): 
genesis1lrx3mrvna9urqcmsph3yffhrea4pj4tedrk7yh
Current NFT ID #58968 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
58968
Accession (UniProt):
Q07E42
Name::
Cystic fibrosis transmembrane conductance regulator
Experimental Method:
Predicted structure
Sequence source:
Dasypus novemcinctus

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q07E42 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q07E42|CFTR_DASNO Cystic fibrosis transmembrane conductance regulator OS=Dasypus novemcinctus OX=9361 GN=CFTR PE=3 SV=1 MQRSPLEKASVISKLFFSWTRPILRKGYRQRLELSDIYQIPSADSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFTFYGIILYLGEVTKAVQPLLLGRIIASYDPDNKVERSIAIYLAVGLCLLFVVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVTLLMGLLWDLLQASAFSGLGVLIILACFQAGFGRMMMKYRDQRAGKINERLVITSEMIENIQSVKAYCWEEALEKMIENFRQSELRLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKSLEYNLTTTDVVMETVTAFWEERFGELFEKAKQNNNNRKISNVDNSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVCYDEYRYRSVIKACQLVEDISKFAEKDNTVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLRPDFSSKLMGYDSFDQFSAERRNSIITETLRRFSLEGDAAHSWNETKKQSFKQTGEFGEKRKNSILNPINSLRRISITQKTPLPMNGIDEDSGETLERRLSLVPDCEQGEGILPRSNLINTGPTLQRGRRQSVLNLMTHSSGNQGQNIHRRTTAFTRKMSLAPQANLVEMDIYSRRLSQDSGLEISEEINEEDLKECFLDDVESIPAVTTWNTYLRYITVHKRLIFVLIWCFVVFLIEVAASLVLLCLLSKVSPEDKGNTTKSANDSSAVIITSTSSFYFLYIYVGVADTFLALGLFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAVAVVSILKPYIFLATVPVIVAFVLLRAYFLHTSQQLKQLESEARSPIFTHLVTSLKGLWTLRAFGRQPYFEALFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGTVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFVDIPTEENKPTKSIKLPKDGQLSKVMIIENQHVKKDDIWPSGGQMTVKDLTAKYIDGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTKGEIQIDGVSWDSITLQEWRKAFGVIPQKVFIFSGTFRKNLDPYGQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGYVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPITYQIIRRTLKQAFADCTVILCEHRIEAMLECQRFLVIEENKVRQYDSIQRLLSEKSLFRQAISPSDRVKLFPHQNSGKHKSRSKITALKEETEEEVQDTRL